Healthcare

The association between type 2 diabetes and risk of death from cancer

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) reveals that type 2 diabetes (T2D) is associated with a 26% increase in the risk of death from cancer in Asians, as well as increases in the risk of death from site-specific cancers that can be even greater.

The authors found that having T2D led to a 26% increase in the risk of dying from any form of cancer, even when taking into account factors such as BMI, alcohol consumption and smoking.

They also found statistically significant links between T2D and the risk of death from specific cancers, with data consistent with that reported in Western countries showing increased risk of death from cancers of liver, pancreas, bile duct, colorectum, and breast associated with T2D.

The strongest association was observed for cancers of the liver, thyroid and kidney (double the risk in each case), and endometrium (2.7 times increased risk) and breast (1.7 times increased risk), relative to individuals who did not have T2D.

Comments

The association between type 2 diabetes and risk of death from cancer

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes) reveals that type 2 diabetes (T2D) is associated with a 26% increase in the risk of death from cancer in Asians, as well as increases in the risk of death from site-specific cancers that can be even greater.

The authors found that having T2D led to a 26% increase in the risk of dying from any form of cancer, even when taking into account factors such as BMI, alcohol consumption and smoking.

They also found statistically significant links between T2D and the risk of death from specific cancers, with data consistent with that reported in Western countries showing increased risk of death from cancers of liver, pancreas, bile duct, colorectum, and breast associated with T2D.

The strongest association was observed for cancers of the liver, thyroid and kidney (double the risk in each case), and endometrium (2.7 times increased risk) and breast (1.7 times increased risk), relative to individuals who did not have T2D.

Comments